The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
- PMID:11316157
- DOI: 10.1111/j.1572-0241.2001.03756.x
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
Abstract
Objective: The aim of this study was to determine the prevalence of the major extraintestinal manifestations of inflammatory bowel disease (IBD) and their relation to disease diagnosis and gender.
Methods: We used the population-based University of Manitoba IBD Database, which includes longitudinal files on all subjects of all health system contacts identified by International Classification of Diseases, 9th Revision, Clinical Modification codes for visit diagnosis. We extracted a cohort from our database, which included subjects with a known diagnosis of IBD for at least 10 yr. We then determined how many contacts each subject had for each of the following extraintestinal IBD-associated immune diseases: primary sclerosing cholangitis, ankylosing spondylitis, iritis/uveitis, pyoderma gangrenosum, and erythema nodosum. We calculated the prevalence of the extraintestinal diseases using an administrative definition of having at least five health system contacts for the diagnosis in question. This administrative definition has previously been validated in Crohn's disease and ulcerative colitis (UC).
Results: A total of 6.2% of patients with IBD had one of six major extraintestinal diseases studied in this report. Only 0.3% of patients had multiple extraintestinal diseases. Iritis/uveitis was the most common extraintestinal disease of all assessed (2.2% of women and 1.1% of men). Iritis/uveitis was more common among women, particularly those with UC (3.8%). Primary sclerosing cholangitis was most common among men with UC (3%). Ankylosing spondylitis was more common among men, and the highest rate was seen among men with Crohn's disease (2.7%). Pyoderma gangrenosum was more common in Crohn's (1.2%) with no gender predilection. Erythema nodosum was similarly present in Crohn's and UC but was more common among women (1.9%).
Conclusions: The associations of immune mediated diseases in extraintestinal sites may help us to further our understanding of IBD pathogenesis, and it may help us in developing a paradigm of disease subsets.
Similar articles
- How prevalent are extraintestinal manifestations at the initial diagnosis of IBD?Isaacs KL.Isaacs KL.Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S198-9. doi: 10.1002/ibd.20597.Inflamm Bowel Dis. 2008.PMID:18816779No abstract available.
- The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.Bernstein CN, Wajda A, Blanchard JF.Bernstein CN, et al.Gastroenterology. 2005 Sep;129(3):827-36. doi: 10.1053/j.gastro.2005.06.021.Gastroenterology. 2005.PMID:16143122
- [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].Kujundzić M.Kujundzić M.Acta Med Croatica. 2013 Apr;67(2):195-201.Acta Med Croatica. 2013.PMID:24471303Review.Croatian.
- Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero-Gómez M.Ampuero J, et al.J Gastroenterol Hepatol. 2014 Feb;29(2):291-5. doi: 10.1111/jgh.12352.J Gastroenterol Hepatol. 2014.PMID:23927379
- Extraintestinal manifestations of Crohn's disease.Juillerat P, Mottet C, Pittet V, Froehlich F, Felley C, Gonvers JJ, Vader JP, Michetti P.Juillerat P, et al.Digestion. 2007;76(2):141-8. doi: 10.1159/000111029. Epub 2008 Feb 7.Digestion. 2007.PMID:18239406Review.
Cited by
- Extraintestinal manifestations and complications in IBD.Ott C, Schölmerich J.Ott C, et al.Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):585-95. doi: 10.1038/nrgastro.2013.117. Epub 2013 Jul 9.Nat Rev Gastroenterol Hepatol. 2013.PMID:23835489Review.
- Respiratory involvement in inflammatory bowel diseases.D'Andrea N, Vigliarolo R, Sanguinetti CM.D'Andrea N, et al.Multidiscip Respir Med. 2010 Jun 30;5(3):173-82. doi: 10.1186/2049-6958-5-3-173.Multidiscip Respir Med. 2010.PMID:22958334Free PMC article.
- Beyond the Gut: The Epidemiology of Extraintestinal Manifestations in Inflammatory Bowel Disease.Boneschansker L, Burke KE.Boneschansker L, et al.Clin Transl Gastroenterol. 2023 Dec 1;14(12):e00618. doi: 10.14309/ctg.0000000000000618.Clin Transl Gastroenterol. 2023.PMID:38156785Free PMC article.
- Extraintestinal Manifestations of Inflammatory Bowel Disease.Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G.Vavricka SR, et al.Inflamm Bowel Dis. 2015 Aug;21(8):1982-92. doi: 10.1097/MIB.0000000000000392.Inflamm Bowel Dis. 2015.PMID:26154136Free PMC article.Review.
- Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature.Angeletti A, Arrigo S, Madeo A, Molteni M, Vietti E, Arcuri L, Coccia MC, Gandullia P, Ghiggeri GM.Angeletti A, et al.BMC Nephrol. 2021 Apr 22;22(1):146. doi: 10.1186/s12882-021-02358-2.BMC Nephrol. 2021.PMID:33888087Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Research Materials